A fully funded, Tier‑1 U.S. uranium explorer aiming to turn Copper Mountain’s historic data and modern assay upgrades into a district‑scale NI 43‑101 resource—highly levered upside, but binary drill-bit and dilution risk.
Overview
Myriad Uranium Corp. is a pre-revenue, exploration-stage uranium company listed on the CSE (M), OTCQB (MYRUF), and Frankfurt (C3Q), focused on acquiring and advancing uranium assets in politically stable North American jurisdictions. The company’s business model is not current uranium production but geological de-risking: expanding and validating pounds-in-the-ground until assets can be monetized through a sale to a major producer, a joint venture, or an eventual move into production. The flagship asset is the Copper Mountain Uranium Project in Wyoming—an exceptionally large district-scale land package with multiple historic mines (including the Arrowhead mine with ~500,000 lbs historical U3O8 production), seven historical deposits, and fifteen additional high-priority targets. Myriad earned a 75% interest by spending >C$5.5M under an earn-in and then moved to eliminate the ownership discount by signing a definitive February 2026 merger agreement to acquire Rush Rare Metals and consolidate 100% of Copper Mountain. The company also holds 100% of the Red Basin Uranium Project in New Mexico, where it completed high-resolution ground geophysics in late 2025. Although Myriad has legacy interests in Niger (Tim Mersoi Basin licenses) and Nova Scotia (Millen Mountain), capital and operational focus have decisively shifted to the U.S. to capture jurisdictional premiums amid nuclear fuel supply-chain onshoring and a tightening uranium market. Overall, Myriad offers high-beta exposure to a uranium bull cycle with value driven by drill results, resource definition, and corporate consolidation rather than operating cash flow.